Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current statusEric M. Parker, Andrew W. Stamford, Margaret van Heek|European Journal of Pharmacology|2002Cited by 97
Abstract 1586: Ezetimibe Reduces Hepatic Steatosis in Diet-Induced Obese MiceJoyce Hwa, Harry R. Davis, Lu Yang et al.|Circulation|2006Cited by 0